Hidayana Irma, Amir Sulfikar, Pelupessy Dicky C, Rahvenia Zahira
Department Asian Studies/Public Health, St. Lawrence University, Canton, New York, United States of America.
LaporCovid19.org- Bona Indah Plaza A2-B11, Lebak Bulus, Jakarta, Indonesia.
PLOS Glob Public Health. 2022 Oct 28;2(10):e0000934. doi: 10.1371/journal.pgph.0000934. eCollection 2022.
Since January 2021, Indonesia has administered a nationwide COVID-19 vaccination. This study examined vaccine intention and identified reasons for vaccine hesitancy in the capital city of Jakarta. This is a cross-sectional online survey using the Health Belief Model (HBM) to assess vaccine intent predictors and describe reasons for hesitancy among Jakarta residents. Among 11,611 respondents, 92.99% (10.797) would like to get vaccinated. This study indicated that all HBM constructs predict vaccine intention (P< 0.05). Those with a high score of perceived susceptibility to the COVID-19 vaccine were significantly predicted vaccine hesitancy (OR = 0.18, 95% CI: 0.16-0.21). Perceived higher benefits of COVID-19 vaccine (OR = 2.91, 95% CI: 2.57-3.28), perceived severity of COVID-19 disease (OR: 1.41, 95% CI: 1.24-1.60), and perceived susceptibility of the current pandemic (OR = 1.21, 95% CI: 1.06-1.38) were significantly predicted vaccination intend. Needle fears, halal concerns, vaccine side effects, and the perception that vaccines could not protect against COVID-19 disease emerged as reasons why a small portion of the respondents (n = 814, 7.23%) are hesitant to get vaccinated. This study demonstrated a high COVID-19 vaccine intention and highlighted the reasons for vaccine refusal, including needle fears, susceptibility to vaccine efficacy, halal issues, and concern about vaccine side effects. The current findings on COVID-19 vaccination show that the government and policymakers should take all necessary steps to remove vaccine hesitancy by increasing awareness of vaccine efficacy and benefit interventions.
自2021年1月以来,印度尼西亚在全国范围内开展了新冠疫苗接种工作。本研究调查了疫苗接种意愿,并确定了雅加达首都居民对疫苗犹豫的原因。这是一项采用健康信念模型(HBM)的横断面在线调查,以评估疫苗接种意愿的预测因素,并描述雅加达居民犹豫的原因。在11611名受访者中,92.99%(10797人)愿意接种疫苗。本研究表明,健康信念模型的所有构成要素均能预测疫苗接种意愿(P<0.05)。新冠疫苗感知易感性得分高的人群显著预测了疫苗犹豫(比值比=0.18,95%置信区间:0.16-0.21)。新冠疫苗感知更高的益处(比值比=2.91,95%置信区间:2.57-3.28)、新冠疾病感知严重性(比值比:1.41,95%置信区间:1.24-1.60)以及当前大流行的感知易感性(比值比=1.21,95%置信区间:1.06-1.38)显著预测了疫苗接种意愿。对针头的恐惧、清真问题、疫苗副作用以及认为疫苗无法预防新冠疾病成为一小部分受访者(n=814,7.23%)对接种疫苗犹豫的原因。本研究显示了较高的新冠疫苗接种意愿,并突出了拒绝接种疫苗的原因,包括对针头的恐惧、对疫苗效力的怀疑、清真问题以及对疫苗副作用的担忧。目前关于新冠疫苗接种的研究结果表明,政府和政策制定者应采取一切必要措施,通过提高对疫苗效力和效益干预措施的认识来消除疫苗犹豫。